Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 December 2019 Photo Shaari Rai Poken
Kweku
From Bloemfontein to Bremen: Kweku Gavor represented South Africa well in Germany.

It all started with the Umoja Buddy Programme (UBP). Kweku Gavor was a UBP ambassador when he met exchange students from Germany. Two years later, the roles were reversed. “Helping out students who later have become my really good friends opened up the opportunity for me to study abroad in Germany.” he said.

Kweku spent about four months as part of a pilot Summer Lab Programme at Universität Bremen after being nominated for a scholarship by the German Academic Exchange Service, which his former Umoja buddies helped create. He shared the experience with eight other students from Palestine, Poland, Ukraine, and the US. The focus was on Business Studies, Marketing and Economics.

According to the BCom graduate, studying internationally gave him new insights. “The experience opened my mind and better-equipped me to work in situations in which I need to handle a lot of pressure against the clock.”

The first leg of the programme featured corresponding modules presented in a classroom environment, which were integrated with assignments, presentations, tests and exams. This was supplemented by a language course that involved cultural leadership training. Another crucial part of the Summer Lab Programme was an internship where students were placed with companies and tasked with a problem-solving project. Kweku was placed at Fabular Ai, an artificial intelligence company which designs computer software.

“Going to study abroad is an extremely rare and fantastic opportunity I advise all who can to grab it with both hands,” said Kweku, who also used the opportunity to travel all over Europe.

Internationalisation at home with Umoja

The UBP, which is collaboratively run by the UFS Office for International Affairs and Student Affairs, played a big part in Kweku being given the opportunity to study abroad. However, unlike him, not all students have to the opportunity to engage in undergraduate exchanges.

The UBP is part of the university’s efforts to advance internationalisation at home, as anchored in the UFS Strategic Plan: 2018-2022. With the programme, students are able to receive an international experience on home ground.

The programme aims to connect international and local students through meaningful lifelong friendships and foster their academic, social and cultural integration. It pairs first-entry international students with senior Kovsies who provide a warm, welcoming, friendly face, and a helping hand.

Expression of interest sought

A total of 48 ambassadors were enrolled in 2019. To join the UBP in 2020, contact Sonya Kapfumvuti at KapfumvutiSCR@ufs.ac.za or call her on 051 401 3397.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept